Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the Phase 2 KEYNOTE-087 study Meeting Abstract


Authors: Zinzani, P. L.; Fanale, M. A.; Chen, R.; Armand, P.; Johnson, N.; Brice, P.; Radford, J.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; Tresckow, B.; Shipp, M. A.; Zhang, Y.; Balakumaran, A.; Moskowitz, C. H.
Abstract Title: Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the Phase 2 KEYNOTE-087 study
Meeting Title: 14th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2017 Jun 14-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2017-06-07
Start Page: 136
End Page: 137
Language: English
ACCESSION: 123459850
DOI: 10.1002/hon.2437_125
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: 126 -- Accession Number: 123459850 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz